Literature DB >> 18603262

Genetic risk factors and markers for Alzheimer's disease and/or depression in the VITA study.

Edna Grünblatt1, Sonja Zehetmayer, Jasmin Bartl, Christiane Löffler, Ildiko Wichart, Michael K Rainer, Susanne Jungwirth, Peter Bauer, Walter Danielczyk, Karl-Heinz Tragl, Peter Riederer, Peter Fischer.   

Abstract

OBJECTIVES: In ageing population, both Alzheimer's disease (AD) and depression are common. Significant depressive symptoms are often co-morbid with cognitive impairment and dementia. In this study, we attempted to find various factors and markers for both AD and depression in a longitudinal cohort, the Vienna-Transdanube-Aging (VITA)-study.
METHODS: The VITA-Study consisted of 305 healthy subjects, 174 subjects with depression only, 55 subjects diagnosed with AD only and 72 subjects with depression as well as AD. Associations between AD and/or depression to gene polymorphisms APO E (epsilon4), choline acetyltransferase (ChAT) 4G to A, serotonin-transporter gene promoter-length, dopamine-D4-receptor, ciliary-neurotrophic-factor-null mutation and brain-derived neurotrophic factor (C270T) and to various known factors were analyzed.
RESULTS: AD and depression were significant associated. Significant risk factors found for AD were low education, low folic acid and depressive-symptoms, while for depression were low education and higher nonsteroidal anti-inflammatory drugs (NSAID) consume. Moreover, the ChAT polymorphism associated significant to depression. Gender, education, and ChAT significantly associated with the combination AD and/or depression.
CONCLUSION: Such studies must be conducted cautiously, as co-morbidities and gene-environmental-social influences may sway the results dramatically. We found in the VITA-study significant association between depression and AD and between ChAT polymorphism and depression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18603262     DOI: 10.1016/j.jpsychires.2008.05.008

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  15 in total

Review 1.  Diabetes type II: a risk factor for depression-Parkinson-Alzheimer?

Authors:  Peter Riederer; Jasmin Bartl; Gerd Laux; Edna Grünblatt
Journal:  Neurotox Res       Date:  2010-06-15       Impact factor: 3.911

2.  Apathy and APOE4 are associated with reduced BDNF levels in Alzheimer's disease.

Authors:  Antón Alvarez; Manuel Aleixandre; Carlos Linares; Eliezer Masliah; Herbert Moessler
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

3.  Near-infrared spectroscopy (NIRS) and vagus somatosensory evoked potentials (VSEP) in the early diagnosis of Alzheimer's disease: rationale, design, methods, and first baseline data of the Vogel study.

Authors:  Thomas Polak; Martin J Herrmann; Laura D Müller; Julia B M Zeller; Andrea Katzorke; Matthias Fischer; Fabian Spielmann; Erik Weinmann; Leif Hommers; Martin Lauer; Andreas J Fallgatter; Jürgen Deckert
Journal:  J Neural Transm (Vienna)       Date:  2017-09-01       Impact factor: 3.575

Review 4.  Stress induced neural reorganization: A conceptual framework linking depression and Alzheimer's disease.

Authors:  Jennifer A Ross; Gediminas Gliebus; Elisabeth J Van Bockstaele
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-08-10       Impact factor: 5.201

5.  Four cases of dysthymic disorder and general malaise successfully treated with traditional herbal (kampo) medicines: kamiuntanto.

Authors:  Toshiaki Kogure; Takeshi Tatsumi; Yuko Oku
Journal:  Integr Med Insights       Date:  2010-05-03

6.  A novel study and meta-analysis of the genetic variation of the serotonin transporter promoter in the italian population do not support a large effect on Alzheimer's disease risk.

Authors:  Letizia Polito; Francesca Prato; Serena Rodilossi; Eleonora Ateri; Daniela Galimberti; Elio Scarpini; Francesca Clerici; Claudio Mariani; Gianluigi Forloni; Diego Albani
Journal:  Int J Alzheimers Dis       Date:  2011-06-02

7.  Behavioural genetics of Alzheimer's disease: a comprehensive review.

Authors:  Marcin Flirski; Tomasz Sobow; Iwona Kloszewska
Journal:  Arch Med Sci       Date:  2011-05-17       Impact factor: 3.318

Review 8.  Genetic Association of CHAT rs3810950 and rs2177369 Polymorphisms with the Risk of Alzheimer's Disease: A Meta-Analysis.

Authors:  Yong Liu; Qicong Chen; Xu Liu; Mengmeng Dou; Silu Li; Jiahui Zhou; Hong Liu; Yongfu Wu; Zunnan Huang
Journal:  Biomed Res Int       Date:  2016-08-15       Impact factor: 3.411

Review 9.  Association of Choline Acetyltransferase Gene Polymorphisms (SNPs rs868750G/A, rs1880676G/A, rs2177369G/A and rs3810950G/A) with Alzheimer's Disease Risk: A Meta-Analysis.

Authors:  Hai Yuan; Qing Xia; Kang Ling; Xiaotong Wang; Xiumin Wang; Xunping Du
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

10.  Polymorphisms of CHAT but not TFAM or VR22 are Associated with Alzheimer Disease Risk.

Authors:  Lili Gao; Yan Zhang; Jinghua Deng; Wenbing Yu; Yunxia Yu
Journal:  Med Sci Monit       Date:  2016-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.